Overview
Good Clinical Practice (GCP) Training is an educational program designed to teach professionals the ethical and scientific quality standards for designing, conducting, recording, and reporting clinical trials involving human subjects. This training ensures that clinical trial personnel understand their responsibilities and can conduct trials in accordance with regulatory requirements. This guide explains what GCP training covers and who needs to complete it.
What Does GCP Training Cover?
GCP Training covers a wide range of topics essential for clinical research compliance, including:
- ICH E6(R3) principles and their application to clinical trials
- Health Canada Division 5 requirements for Canadian trials
- FDA regulations including 21 CFR Parts 50, 56, 312, and 314
- Informed consent processes and documentation
- Investigator and sponsor responsibilities
- Data governance and integrity requirements
- Safety reporting and pharmacovigilance
- Quality management and risk-based approaches
- Auditing practices based on ISO 19011:2026
Training also covers specific operational areas such as source documentation, adverse event reporting, and Trial Master File management.
Who Needs GCP Training?
GCP Training is required for all personnel involved in clinical trial-related activities. This includes:
- Clinical Investigators and Sub-Investigators
- Clinical Research Associates (Monitors) and site staff
- Research Coordinators and study nurses
- Sponsor Personnel including medical, regulatory, and clinical operations
- IRB/IEC Members and coordinators
- Data Management and biostatistics professionals
- Quality Assurance and compliance staff
- Pharmacovigilance and safety specialists
- Regulatory Affairs professionals
- Clinical Research Organization (CRO) personnel
Anyone who handles trial data, interacts with participants, or manages trial-related activities requires GCP training.
Detailed Course Breakdown
Course 1: Health Canada Good Clinical Practice Training
This comprehensive training program provides participants with a thorough understanding of Good Clinical Practice (GCP) requirements specific to the Canadian regulatory environment.
Scope: The program covers Health Canada’s Part C, Division 5 of the Food and Drug Regulations, GUI-0100, and the ICH E6(R3) guideline.
Description of Modules: The curriculum covers:
- Introduction to GCP and its importance in clinical research
- Health Canada Part C, Division 5 regulatory requirements
- ICH E6(R3) principles and Annex 1 provisions
- Informed consent processes and documentation
- Investigator responsibilities and site management
- Sponsor responsibilities and oversight
- Data governance and record-keeping requirements
- Essential records and Trial Master File management
- Safety reporting and pharmacovigilance
- Quality management and risk-based approaches
Target Audience:
- Clinical Investigators and Sub-Investigators
- Clinical Research Associates (Monitors)
- Research Coordinators and Site Staff
- Sponsor Personnel (Medical, Regulatory, Clinical Operations)
- IRB/IEC Members and Coordinators
- Data Management and Biostatistics Professionals
- Quality Assurance and Compliance Staff
Pricing: Competitive pricing with group discounts available.
FAQ:
- What is the definition of GCP? GCP is an international ethical and scientific quality standard for designing, conducting, recording, and reporting clinical trials that involve human subjects.
- Who requires GCP training in Canada? Anyone involved in clinical trial-related activities in Canada requires GCP training, including investigators, monitors, coordinators, and sponsor personnel.
- What is the difference between GCP and GLP? GCP covers clinical trials involving human subjects, while GLP covers nonclinical laboratory studies.
- How often should GCP training be updated? Training should be updated annually to reflect regulatory changes and industry best practices.
- Is GCP training mandatory for IRB members? Yes, IRB/IEC members should have GCP training to understand their responsibilities for ethical review of clinical trials.
Enroll Now: https://www.gxptrainings.com/courses/health-canada-good-clinical-practice-training/
Course 2: Good Clinical Practices (ICH E6(R3) Focused)
This comprehensive training program provides an in-depth exploration of the ICH E6(R3) Good Clinical Practice guideline.
Scope: The curriculum is structured to guide participants through the entire guideline, covering the 11 fundamental principles, the expanded roles and responsibilities of sponsors and investigators, rigorous data governance frameworks, and the critical requirements for essential records.
Description of Modules: The curriculum covers:
- ICH E6(R3) overview and its significance in global clinical research
- 11 Fundamental Principles of GCP and their application
- Sponsor responsibilities including oversight and quality management
- Investigator responsibilities including delegation and supervision
- Informed consent requirements and documentation
- Data governance and integrity frameworks
- Essential records and Trial Master File requirements
- Safety reporting and pharmacovigilance obligations
- Risk-based approaches to trial management
- Digital technologies and decentralized trial elements
Target Audience:
- Clinical Investigators and Sub-Investigators
- Sponsor Personnel (Medical, Regulatory, Clinical Operations)
- Clinical Research Associates (Monitors)
- IRB/IEC Members and Coordinators
- Data Management and Biostatistics Professionals
- Quality Assurance and Compliance Staff
- Clinical Trial Coordinators and Site Staff
- Pharmacovigilance and Safety Specialists
- Regulatory Affairs Professionals
Pricing: $149.00 with group discounts available.
FAQ:
- What are the 11 fundamental principles of GCP? The 11 fundamental principles cover the ethical and scientific foundation of clinical trials, including participant safety, data integrity, and quality management.
- What is the role of the sponsor in GCP? Sponsors are responsible for initiating, managing, and financing clinical trials, and ensuring compliance with GCP requirements.
- What is the role of the investigator in GCP? Investigators are responsible for conducting the trial at the site, ensuring participant safety, and complying with the protocol and GCP requirements.
- What is the Trial Master File? The Trial Master File is a collection of essential documents that collectively demonstrate compliance with GCP and regulatory requirements.
- What is the significance of Annex 1 in ICH E6(R3)? Annex 1 provides specific guidance on interventional clinical trials, building on the fundamental principles in the main body of the guideline.
Enroll Now: https://www.gxptrainings.com/courses/ich-e6r3-good-clinical-practices-gcp/
Course 3: GCP Global Auditor Certification Program
This training program defines the complete knowledge and performance requirements for personnel involved in clinical research to become certified global auditors for Good Clinical Practice (GCP).
Scope: The program integrates GCP requirements from ICH E6(R3), Health Canada Part C, Division 5, and FDA regulations with auditing practices based on ISO 19011:2026.
Description of Modules: The curriculum covers 10 comprehensive sections:
- Regulatory Frameworks including ICH E6(R3), Health Canada Division 5, and FDA 21 CFR
- Auditing Practices based on ISO 19011:2026
- Informed consent process auditing
- Institutional Review Board operations auditing
- Investigational New Drug applications auditing
- New Drug Applications auditing
- Postmarketing safety reporting auditing
- Investigator responsibilities auditing
- Sponsor responsibilities auditing
- Remote auditing methods and technology
Target Audience:
- Quality Assurance Personnel
- Clinical Research Associates (Monitors)
- Study Directors and Clinical Trial Managers
- Clinical Investigators and Site Staff
- Sponsor Personnel
- CRO Personnel
- IRB/IEC Members and Coordinators
- Data Management and Biostatistics Professionals
- Pharmacovigilance and Safety Specialists
- Regulatory Affairs Professionals
- Audit Program Managers
Pricing: $499.00 with group discounts available.
FAQ:
- What is the difference between an auditor and a monitor? Monitors oversee trial conduct and data quality, while auditors independently assess compliance with GCP and regulatory requirements.
- What are the key elements of a GCP audit? A GCP audit includes planning, preparation, execution, reporting, and follow-up of corrective actions.
- What is a non-conformity in GCP auditing? A non-conformity is a deviation from GCP requirements that can be classified as major, minor, or observation.
- What is the purpose of remote GCP auditing? Remote auditing enables efficient oversight of global trial sites and vendors, reducing travel costs and time.
- How are audit findings communicated? Audit findings are documented in an audit report and communicated to management for corrective action.
Enroll Now: https://www.gxptrainings.com/courses/gcp-global-auditor-certification-program/
Course 4: HIPAA Clinical Data Privacy, Security & Compliance Training
This training program provides organizations and individuals with a comprehensive understanding of the legal, regulatory, and operational requirements for protecting health information in clinical research and healthcare delivery settings.
Scope: The program covers the full spectrum of privacy, security, and compliance obligations under U.S. federal law and international good practice standards.
Description of Modules: The curriculum covers 10 comprehensive sections:
- HIPAA Overview and regulatory landscape
- HIPAA Privacy Rule requirements and PHI protections
- HIPAA Security Rule requirements and ePHI safeguards
- HIPAA Breach Notification Rule requirements
- GCP and clinical data integrity requirements
- Security controls for information systems and cloud environments
- Regulatory compliance frameworks including FDA, NIST, and ISO
- Incident management and breach response
- Risk assessment methodologies
- Roles and responsibilities of Sponsors, CROs, Investigators, and vendors
Target Audience:
- Covered Entities under HIPAA
- Business Associates and their subcontractors
- Clinical Research Professionals
- Security and Compliance Professionals
Pricing: $249.00 with group discounts available.
FAQ:
- What is Protected Health Information (PHI)? PHI is health information that identifies an individual or can be used to identify an individual, including demographic data, medical records, and test results.
- What is the difference between the HIPAA Privacy Rule and Security Rule? The Privacy Rule protects the privacy of PHI, while the Security Rule establishes standards for protecting ePHI.
- What is a breach under HIPAA? A breach is the unauthorized acquisition, access, use, or disclosure of PHI that compromises the security or privacy of the information.
- What is the role of a Business Associate Agreement? A Business Associate Agreement is a contract between a covered entity and a business associate that establishes the terms for PHI handling and protection.
- How can I ensure HIPAA compliance in clinical research? Compliance requires appropriate policies, training, technical safeguards, and oversight of business associates.
Enroll Now: https://www.gxptrainings.com/courses/hipaa-clinical-data-privacy-security-compliance-training/
Course 5: Certified Regulatory Affairs Professional (CRAP)
This comprehensive certification program provides regulatory professionals with end-to-end knowledge of the global pharmaceutical regulatory landscape.
Scope: The program covers the complete drug development lifecycle from discovery through post-approval lifecycle management, with specific focus on the regulatory requirements of the FDA, EMA, and PMDA.
Description of Modules: The curriculum covers 10 comprehensive sections:
- Global regulatory framework overview
- Investigational New Drug (IND) applications
- New Drug Applications (NDA) for innovative pharmaceuticals
- Abbreviated New Drug Applications (ANDA) for generics
- Biologics License Applications (BLA) for biological products
- Orphan Drug Designation for rare disease treatments
- Special Programs including Accelerated Approval and Breakthrough Therapy
- Post-approval lifecycle management
- Regulatory agency interactions and meeting management
- Global regulatory strategy development
Target Audience:
- Regulatory Affairs Professionals
- Pharmaceutical Development and Formulation Scientists
- Quality Assurance/Quality Control Professionals
- Clinical and Nonclinical Development Professionals
- CMC Specialists and Manufacturing Personnel
- Project Management Professionals
- CRO and CMO Personnel
- Legal and Intellectual Property Professionals
Pricing: $799.00 with group discounts available.
FAQ:
- What is an Investigational New Drug (IND) application? An IND is a submission to the FDA that authorizes the conduct of clinical trials for an investigational drug.
- What is a New Drug Application (NDA)? An NDA is a submission to the FDA that requests marketing approval for a new drug.
- What is the role of the FDA in clinical research? The FDA regulates clinical trials in the US, reviewing INDs and NDAs, and ensuring participant safety and data integrity.
- What is the role of Health Canada in clinical research? Health Canada regulates clinical trials in Canada, reviewing clinical trial applications and ensuring compliance with GCP requirements.
- What is the importance of ICH in global drug development? ICH develops guidelines that harmonize regulatory requirements across regions, facilitating efficient global drug development.
Enroll Now: https://www.gxptrainings.com/courses/certified-regulatory-affairs-professional/
Get Your Team Offer
For organizations looking to enroll multiple participants, we offer specialized team packages and volume discounts. Please reach out to our partnership team to discuss your specific needs and scores.
Contact Us: https://www.gxptrainings.com/contact-us/
Authors
